CNF-201

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCNF-201
Drug Alias NameCNF201
ClassificationOther
Mechanisms of ActionHeat-shock protein inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2Heat-shock protein
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiogen Idec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen Idec
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A